BMRN - CIK 0001048477
BIOMARIN PHARMACEUTICAL INC has filed 2,709 documents with the SEC between 1999 and 2026. The most frequent type is insider trade (1,585 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2026-05-21 | 2026-05-20 |
| Insider trade | 4 | 2026-05-11 | 2026-05-07 |
| Insider sale notice | 144 | 2026-05-07 | - |
| Quarterly report | 10-Q | 2026-05-05 | 2026-03-31 |
| Major company event | 8-K | 2026-05-04 | 2026-05-04 |
| SCHEDULE 13G | - | 2026-04-29 | - |
| Major company event | 8-K | 2026-04-27 | 2026-04-27 |
| Major company event | 8-K | 2026-04-23 | 2026-04-23 |
| Proxy materials | DEFA14A | 2026-04-21 | - |
| Proxy statement | DEF 14A | 2026-04-21 | 2026-06-02 |
| Annual report to shareholders | ARS | 2026-04-21 | 2025-12-31 |
| SCHEDULE 13G/A | - | 2026-03-26 | - |
| Insider trade | 4 | 2026-03-19 | 2026-03-18 |
| Insider trade | 4 | 2026-03-19 | 2026-03-17 |
| Insider trade | 4 | 2026-03-19 | 2026-03-17 |
| Insider trade | 4 | 2026-03-19 | 2026-03-17 |
| Insider trade | 4 | 2026-03-18 | 2026-03-16 |
| Insider trade | 4 | 2026-03-18 | 2026-03-16 |
| Insider trade | 4 | 2026-03-17 | 2026-03-13 |
| Insider trade | 4 | 2026-03-17 | 2026-03-16 |
| Insider trade | 4 | 2026-03-17 | 2026-03-13 |
| Insider trade | 4 | 2026-03-17 | 2026-03-13 |
| Major company event | 8-K | 2026-03-16 | 2026-03-16 |
| Insider trade | 4 | 2026-03-12 | 2026-03-11 |
| Insider sale notice | 144 | 2026-03-11 | - |
| Insider sale notice | 144 | 2026-02-26 | - |
| Insider sale notice | 144 | 2026-02-26 | - |
| Insider trade | 4 | 2026-02-26 | 2026-02-25 |
| Insider trade | 4 | 2026-02-26 | 2026-02-26 |
| Insider trade | 4 | 2026-02-26 | 2026-02-25 |
| Insider trade | 4 | 2026-02-26 | 2026-02-25 |
| Annual report | 10-K | 2026-02-26 | 2025-12-31 |
| Major company event | 8-K | 2026-02-23 | 2026-02-23 |
| Annual insider summary | 5 | 2026-02-13 | 2025-12-31 |
| Annual insider summary | 5 | 2026-02-13 | 2025-12-31 |
| Annual insider summary | 5 | 2026-02-13 | 2025-12-31 |
| Annual insider summary | 5 | 2026-02-13 | 2025-12-31 |
| Annual insider summary | 5 | 2026-02-13 | 2025-12-31 |
| Annual insider summary | 5 | 2026-02-13 | 2025-12-31 |
| Major company event | 8-K | 2026-02-12 | 2026-02-12 |
| Major company event | 8-K | 2026-01-29 | 2026-01-29 |
| Major company event | 8-K | 2026-01-26 | 2026-01-26 |
| Insider trade | 4 | 2026-01-22 | 2026-01-20 |
| New insider ownership | 3 | 2026-01-22 | 2026-01-20 |
| SCHEDULE 13G/A | - | 2026-01-21 | - |
| Major company event | 8-K | 2026-01-12 | 2026-01-12 |
| Major company event | 8-K | 2025-12-22 | 2025-12-19 |
| Major company event | 8-K | 2025-12-19 | 2025-12-19 |
| Major company event | 8-K | 2025-12-17 | 2025-12-11 |
| Insider trade | 4 | 2025-12-02 | 2025-12-01 |